Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 12/20 | 0.78 |
| ▸ | PGR | P06401 | 7/20 | 0.78 |
| ▸ | ABCB11 | O95342 | 3/20 | 0.78 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.78 |
| ▸ | ABCC3 | O15438 | 2/20 | 0.78 |
| ▸ | HIF1A | Q16665 | 5/20 | 0.67 |
| ▸ | LMNA | P02545 | 4/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.67 |
| ▸ | USP2 | O75604 | 1/20 | 0.67 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.67 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.58 |
| ▸ | NR3C2 | P08235 | 3/20 | 0.58 |
| ▸ | AR | P10275 | 2/20 | 0.58 |
| ▸ | TNF | P01375 | 1/20 | 0.58 |
| ▸ | IL6 | P05231 | 1/20 | 0.58 |
| ▸ | SERPINA6 | P08185 | 1/20 | 0.58 |
| ▸ | GLUL | P15104 | 1/20 | 0.58 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.58 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Etiprednol Dicloacetate SCHEMBL4097770 | 1.00 | NR3C1 (0.78) | NR3C1PGRABCB11NR1I2ABCC3 | |
| Etiprednol Dicloacetate SCHEMBL13650061 | 1.00 | NR3C1 (0.78) | NR3C1PGRABCB11NR1I2ABCC3 | |
| Etiprednol Dicloacetate SCHEMBL20589422 | 1.00 | NR3C1 (0.78) | NR3C1PGRABCB11NR1I2ABCC3 | |
| Etiprednol Dicloacetate SCHEMBL13379814 | 1.00 | NR3C1 (0.78) | NR3C1PGRABCB11NR1I2ABCC3 | |
| SCHEMBL8502600 | 0.94 | NR3C1 (0.71) | NR3C1PGRABCB11NR1I2ABCC3 | |
| SCHEMBL7609828 | 0.93 | NR3C1 (0.81) | NR3C1PGRABCB11NR1I2ABCC3 | |
| SCHEMBL8505831 | 0.93 | NR3C1 (0.70) | NR3C1PGRABCB11NR1I2ABCC3 | |
| SCHEMBL7614787 | 0.93 | NR3C1 (0.72) | NR3C1PGRABCB11NR1I2ABCC3 | |
| SCHEMBL7612201 | 0.92 | NR3C1 (0.68) | NR3C1PGRABCB11NR1I2ABCC3 | |
| SCHEMBL7611101 | 0.91 | NR3C1 (0.68) | NR3C1PGRABCB11NR1I2ABCC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230019058-A1 | METHOD FOR THE TREATMENT OF VIRAL INFECTIONS | SOFTHALE NV (BE) | 2023-01-19 | — | — | US | disclosed |
| EP-4117670-A1 | METHOD FOR THE TREATMENT OF A RESPIRATORY DISEASE, DISORDER, OR CONDITION RESULTING FROM A VIRAL INFECTION | Softhale NV (BE) | 2023-01-18 | — | — | EP | disclosed |
| CN-115315261-A | Methods of treating respiratory diseases, disorders or conditions caused by viral infections | 索芙特海尔公司 | 2022-11-08 | — | — | CN | disclosed |
| WO-2021180919-A1 | METHOD FOR THE TREATMENT OF A RESPIRATORY DISEASE, DISORDER, OR CONDITION RESULTING FROM A VIRAL INFECTION | SOFTHALE NV (BE) | 2021-09-16 | — | — | WO | disclosed |
| US-7927613-B2 | Pharmaceutical co-crystal compositions | UNIVERSITY OF SOUTH FLORIDA (US) | 2011-04-19 | — | — | US | disclosed |
| US-7790905-B2 | Pharmaceutical propylene glycol solvate compositions | MCNEIL-PPC, INC. (US) | 2010-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230019058-A1 | METHOD FOR THE TREATMENT OF VIRAL INFECTIONS | IL5, TSLP, CRH | NR3C1 11/4885PGR 2218/4885ABCB11 3861/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.